Department of Chemistry, Sapienza University of Rome, 00185 Roma, Italy.
Anal Biochem. 2010 May 15;400(2):195-202. doi: 10.1016/j.ab.2010.01.039. Epub 2010 Feb 1.
In this study, a magnetic bead-based platform amenable to high-throughput protein carbonic anhydrase II (CA II) capture is presented. The key steps in this approach involved immunoaffinity purification of the target protein from serum followed by on-bead digestion with trypsin to release a surrogate peptide. This tryptic peptide was quantified by liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS) operating in multiple reaction monitoring acquisition mode. Using a synthetic peptide standard and a structural analogue free-labeled internal standard, the resulting concentration was stoichiometrically converted to CA II serum concentration. The analytical steps, such as preparation of immunobeads, protein capture, proteolysis, and calibration, were optimized. The method was validated in terms of recovery (77%), reproducibility (relative standard deviation [RSD]<12%), and method detection limit (0.5 pmol ml(-1)). The developed method was applied to determining the CA II in eight healthy subjects, and the concentration measured was 27.3 pmol ml(-1) (RSD = 65%).
在这项研究中,提出了一种适用于高通量蛋白质碳酸酐酶 II(CA II)捕获的基于磁珠的平台。该方法的关键步骤包括从血清中免疫亲和纯化靶蛋白,然后用胰蛋白酶在珠上进行酶解以释放替代肽。通过液相色谱-电喷雾电离-串联质谱(LC-ESI-MS/MS)在多反应监测采集模式下定量分析该胰蛋白酶肽。使用合成肽标准品和结构类似物无标记内标,将所得浓度按化学计量比转化为 CA II 血清浓度。优化了免疫珠制备、蛋白质捕获、蛋白水解和校准等分析步骤。该方法在回收率(77%)、重现性(相对标准偏差[RSD] <12%)和方法检测限(0.5 pmol ml(-1))方面进行了验证。该方法应用于测定 8 位健康受试者的 CA II,测得的浓度为 27.3 pmol ml(-1)(RSD = 65%)。